Report cover image

Vectura Group Plc - Product Pipeline Analysis, 2022 Update

Publisher GlobalData
Published Jul 22, 2022
Length 36 Pages
SKU # GBDT17335410

Description

Summary

Vectura Group Plc (Vectura) is a formulation, device design and development company. It focuses on the development of inhaled airways products through an integrated inhaled drug delivery platform. Its major products include dry powder inhalers (DPI) and metered dose inhalers (MDI) for patients suffering from airways diseases such as asthma, chronic obstructive pulmonary disease (COPD) and other ailments. It offers formulation development, pharmaceutical analysis, device platforms, process development & technical transfer, product manufacturing and regulatory services. It has partnership and license agreements with global biotechnology and pharmaceutical companies to develop a portfolio of drugs, including inhaled in-market products and inhaled generics. Vectura is headquartered in Chippenham, Wiltshire, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:
  • The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
  • The report analyzes all pipeline products in development for the company Vectura Group Plc
  • The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
  • The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
  • The report provides detailed description of products in development, technical specification and functions
  • The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
  • Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
  • Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
  • To formulate effective Research & Development strategies
  • Develop market-entry and market expansion strategies
  • Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
  • Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
  • Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company

Table of Contents

36 Pages
Vectura Group Plc Company Overview
Vectura Group Plc Company Snapshot
Vectura Group Plc Pipeline Products and Ongoing Clinical Trials Overview
Vectura Group Plc – Pipeline Analysis Overview
Business Description
Vectura Group Plc - Key Facts
Vectura Group Plc - Major Products and Services
Vectura Group Plc Pipeline Products by Development Stage
Vectura Group Plc Ongoing Clinical Trials by Trial Status
Vectura Group Plc Pipeline Products Overview
Digitally - Connected LOMI Device
Digitally - Connected LOMI Device Product Overview
Flutiform pMDI
Flutiform pMDI Product Overview
FOX Vibrating Mesh Nebulizer
FOX Vibrating Mesh Nebulizer Product Overview
MRX006 - Multidose Combined DPI Inhaler
MRX006 - Multidose Combined DPI Inhaler Product Overview
SKP-2075
SKP-2075 Product Overview
VR475 Combination Device
VR475 Combination Device Product Overview
VR647
VR647 Product Overview
VR647 Clinical Trial
Vectura Group Plc - Key Competitors
Vectura Group Plc - Key Employees
Vectura Group Plc - Key Employee Biographies
Vectura Group Plc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Vectura Group Plc, Recent Developments
Jun 10, 2021: Vectura announces completion of management buy-out of Lyon oral subsidiary, Skyepharma Production
May 27, 2021: Vectura Group announce Directorate Change
Apr 23, 2021: Vectura Group announce 2020 Annual Report, 2021 AGM notice & GM circular
Mar 18, 2021: Vectura Group Announces 2020 Preliminary Results
Jan 12, 2021: Vectura Group: Trading update
Apr 17, 2020: Vectura presents latest science at Digital RDD 2020
Nov 27, 2019: VR315US: Hikma submits response to FDA
Oct 29, 2019: Vectura Group appoints New Chief Executive Officer
Oct 22, 2019: Vectura to present latest science at Drug Delivery to the Lungs (DDL) 2019
Oct 04, 2019: UK court dismisses GSK's claims of passing off in respect of Sandoz's AirFluSal Forspiro
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Table 1: Vectura Group Plc Pipeline Products and Ongoing Clinical Trials Overview
Table 2: Vectura Group Plc Pipeline Products by Equipment Type
Table 3: Vectura Group Plc Pipeline Products by Indication
Table 4: Vectura Group Plc, Key Facts
Table 5: Vectura Group Plc, Major Products and Services
Table 6: Vectura Group Plc Number of Pipeline Products by Development Stage
Table 7: Vectura Group Plc Pipeline Products Summary by Development Stage
Table 8: Vectura Group Plc Ongoing Clinical Trials by Trial Status
Table 9: Vectura Group Plc Ongoing Clinical Trials Summary
Table 10: Digitally - Connected LOMI Device - Product Status
Table 11: Digitally - Connected LOMI Device - Product Description
Table 12: Flutiform pMDI - Product Status
Table 13: Flutiform pMDI - Product Description
Table 14: FOX Vibrating Mesh Nebulizer - Product Status
Table 15: FOX Vibrating Mesh Nebulizer - Product Description
Table 16: MRX006 - Multidose Combined DPI Inhaler - Product Status
Table 17: MRX006 - Multidose Combined DPI Inhaler - Product Description
Table 18: SKP-2075 - Product Status
Table 19: SKP-2075 - Product Description
Table 20: VR475 Combination Device - Product Status
Table 21: VR475 Combination Device - Product Description
Table 22: VR647 - Product Status
Table 23: VR647 - Product Description
Table 24: VR647 - A Phase I Clinical Study of VR-647
Table 25: VR647 - A Phase I Clinical Study of VR-647 in Adult Asthma Subjects
Table 26: VR647 - Phase II Pharmacokinetic Study of VR-647 in Children
Table 27: VR647 - Phase III Study of VR-647
Table 28: Vectura Group Plc, Key Employees
Table 29: Vectura Group Plc, Key Employee Biographies
Table 30: Vectura Group Plc, Other Locations
Table 31: Vectura Group Plc, Subsidiaries
Table 32: Glossary
List of Figures
Figure 1: Vectura Group Plc Pipeline Products by Equipment Type
Figure 2: Vectura Group Plc Pipeline Products by Development Stage
Figure 3: Vectura Group Plc Ongoing Clinical Trials by Trial Status

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us